Colonic delivery of dexamethasone: A pharmacoscintigraphic clinical evaluation

Proceedings of the Controlled Release Society

Volumn , Issue 23, 1996, Pages 553-554

  Kenyon, C ^a   Nardi, R ^a   Wong, D ^a   Hooper, G ^a   Wilding, I ^a   Friend, D ^a  

^a CIBUS Pharmaceutical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; BETA MANNOSIDASE; CORTICOSTEROID; DEXAMETHASONE; GUAR GUM;

BIODEGRADATION; CLINICAL TRIAL; COLON; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; DRUG TISSUE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; LONG TERM CARE; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SCINTIGRAPHY; SIDE EFFECT; ULCERATIVE COLITIS; VISCOSITY;

EID: 0029790577     PISSN: 10220178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)